Sarah Tasian is an Oncology physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 401 publications with 8,526 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 Civic Center Blvd
Children'S Hospital Of Philadelphia - Hem/onc
Philadelphia, PA 191044319
Telephone
215-590-3535Registry record last updated 16 Apr 2013.
Clinical trials
- Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: St. Jude Children's Research Hospital
- Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Sponsor: Children's Hospital Medical Center, Cincinnati
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202517 payments$12,313openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year20253 payments
- JAZZ PHARMACEUTICALS INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2014–2024 per NIH RePORTER. The latest:
- Towards rational design of combination therapeutic targets
Children'S Hosp of Philadelphia
FY2024$446,027U01CA243072 - Towards rational design of combination therapeutic targets
Children'S Hosp of Philadelphia
FY2023$509,159U01CA243072 - Towards rational design of combination therapeutic targets
Children'S Hosp of Philadelphia
FY2022$524,014U01CA243072
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jonathan Spergel, MD
Children's Hospital of Philadelphia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”